Genmab



Ebitda Veränderung Datum
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Almirall EUR 84.73M 39K 2024-12
Amarin USD -24415000 24.65M 2024-09
Amgen USD 3.75B 42M 2025-03
argenx SE 88.7M 103.13M 2024-09
AstraZeneca USD 5.08B 182M 2025-03
Bayer EUR 3.59B 1.92B 2025-03
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Demant DKK 1.96B 1.65B 2020-12
Exelixis USD 194.2M 23.1M 2025-04
Fresenius Medical Care EUR 589M 34.68M 2025-03
Galapagos EUR -158708000 177.84M 2025-03
Genmab DKK 204M 2.03B 2025-03
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
GN Store Nord DKK 681M 242M 2025-03
GRIFOLS EUR 405.59M 130.51M 2025-03
Hikma Pharmaceutical USD 453M 98M 2024-06
Insmed USD -226016000 15.78M 2025-03
Lonza CHF 873M 107M 2024-06
Merck EUR 1.42B 203M 2024-12
Novartis USD 5.19B 319M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
UCB EUR 652M 105M 2024-06



Genmab - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.